Fabry disease, also known as Anderson–Fabry disease, is a rare genetic disease that can affect many parts of the body, including the kidneys, heart, brain... 39 KB (4,006 words) - 02:53, 8 March 2024 |
Α-Galactosidase (section Fabry disease) galactose and glucose.[citation needed] Defects in human α-GAL result in Fabry disease, a rare lysosomal storage disorder and sphingolipidosis that results... 31 KB (3,128 words) - 05:53, 13 April 2024 |
members of this group are Niemann–Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay–Sachs disease and metachromatic leukodystrophy. They... 10 KB (651 words) - 23:02, 18 March 2024 |
Lipid storage disorder (redirect from Lipid storage disease) Members of this group include Niemann-Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay–Sachs disease, metachromatic leukodystrophy, multiple... 6 KB (663 words) - 14:33, 27 October 2023 |
disease – Sir James Paget Fabry disease – Johannes Fabry Fanconi anemia – Guido Fanconi Fanconi syndrome – Guido Fanconi Farber disease – Sidney Farber Felty's... 62 KB (6,446 words) - 06:48, 31 March 2024 |
for some lysosomal storage diseases: Gaucher disease, Fabry disease, MPS I, MPS II (Hunter syndrome), MPS VI and Pompe disease. ERT does not correct the... 13 KB (1,367 words) - 23:00, 31 December 2023 |
under the brand name Galafold, is a medication for the treatment of Fabry disease, a rare genetic disorder. It was developed by Amicus Therapeutics. The... 16 KB (1,414 words) - 05:45, 13 April 2024 |